Search Results - Christopher Horvath

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils.

    Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophils. by Christopher Horvath, Thomas J. Ferro, Gary Jesmok, Asrar B. Malik

    Published 1988
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway–mediated diseases

    Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway–mediated diseases by Masha Fridkis‐Hareli, Michael Storek, István Mazsaroff, Antonio M. Risitano, Ante S. Lundberg, Christopher Horvath, V. Michael Holers

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Non-thermal ablation of neural tissue with femtosecond laser pulses

    Non-thermal ablation of neural tissue with femtosecond laser pulses by Frieder H. Loesel, Joerg Fischer, Marcus Götz, Christopher Horvath, T. Juhász, F. Noack, Norbert Suhm, Josef F. Bille

    Published 1998
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Effective Targeting of Multiple B-Cell Maturation Antigen–Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells

    Effective Targeting of Multiple B-Cell Maturation Antigen–Expressing Hematological Malignances by Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor T Cells by Kevin M. Friedman, Tracy E. Garrett, John Evans, Holly M. Horton, Howard J. Latimer, Stacie L. Seidel, Christopher Horvath, Richard A. Morgan

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    First-in-Human Evaluation of Anti–von Willebrand Factor Therapeutic Aptamer ARC1779 in Healthy Volunteers

    First-in-Human Evaluation of Anti–von Willebrand Factor Therapeutic Aptamer ARC1779 in Healthy Volunteers by James C. Gilbert, Tia DeFeo-Fraulini, Renta Hutabarat, Christopher Horvath, Patricia G. Merlino, H. Nicholas Marsh, Judith M. Healy, Sleiman BouFakhreddine, Thomas V. Holohan, Robert G. Schaub

    Published 2007
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment opsonization

    The complement receptor 2/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement-mediated hemolysis and C3 fragment opsonization by Antonio M. Risitano, Rosario Notaro, Caterina Pascariello, Michela Sica, Luigi Del Vecchio, Christopher Horvath, Masha Fridkis‐Hareli, Carmine Selleri, Margaret A. Lindorfer, Ronald P. Taylor, Lucio Luzzatto, V. Michael Holers

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: